Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Oral Contraceptive Pills Market Forecast: What Value Will The Market Reach By 2030?
The oral contraceptive pills market has experienced significant growth in recent years. It is anticipated to increase from $30.43 billion in 2025 to $34.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.9%. The market’s historical expansion can be attributed to several factors including heightened awareness of family planning, the availability of generic pills, supportive government healthcare policies, a growing prevalence of unintended pregnancies, and the expansion of hospital pharmacy networks.
The oral contraceptive pills market size is anticipated to undergo significant expansion over the next few years. It is projected to reach $61.05 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 15.0%. This expected growth during the forecast period is primarily driven by factors such as the emergence of digital healthcare platforms, innovations in drug delivery technology, a rise in women’s health initiatives, the expansion of online retail channels, and a surging demand for personalized contraceptive solutions. Prominent trends for the upcoming period include greater awareness of hormonal contraceptives, increased uptake of online pharmacies, the expansion of generic oral contraceptives, a focus on low-dose and non-hormonal pill options, and the broadening of women’s health programs.
Get A Free Sample Report With In-Depth Market Insights:
Oral Contraceptive Pills Market Expansion Drivers: What’s Shaping Future Growth?
Increasing healthcare spending is anticipated to boost the expansion of the oral contraceptive pill market in the future. Healthcare expenditure refers to the total amount of resources, including financial resources, spent on healthcare services and products within a specific period. This rise in spending improves overall healthcare accessibility, which in turn facilitates greater adoption of oral contraceptive pills. This occurs through enhanced access to family planning services, medical consultations, and affordable prescriptions, thereby driving market expansion. For instance, in December 2024, the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, stated that U.S. health care expenditures increased by 7.5% in 2023, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, rising healthcare expenditures are driving the growth of the oral contraceptive pills market.
Oral Contraceptive Pills Market Segment Outlook: Which Categories Are Growing Fastest?
The oral contraceptive pills market covered in this report is segmented –
1) By Type: Combination, Progestin Only, Other Types
2) By Category: Generic, Branded
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels
Subsegments:
1) By Combination Pills: Monophasic Combination Pills, Multiphasic Combination Pills, Extended-Cycle Combination Pills
2) By Progestin-Only Pills: Daily Progestin-Only Pills, Progestin-Only Emergency Contraceptive Pills
3) By Other Types: Low-Dose Oral Contraceptive Pills, High-Dose Oral Contraceptive Pills, Non-Hormonal Oral Contraceptives (In Development Or Alternative Formulations)
Oral Contraceptive Pills Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies within the oral contraceptive pill market are developing innovative products, such as progestin-only oral contraceptives, aiming to cater to broader customer bases, boost sales, and increase revenue. Progestin-only oral contraceptives are a category of birth control pills that contain exclusively a synthetic form of the hormone progestin. For instance, in July 2023, Perrigo Company PLC, an Ireland-based manufacturer of oral contraceptive pills, announced the U.S. Food and Drug Administration (FDA) approval for Opill. Opill, as the first over-the-counter birth control pill available in the United States, represents a significant breakthrough in women’s reproductive health. Being a progestin-only pill, Opill not only offers effective pregnancy prevention but also establishes enhanced accessibility for women. Its availability without a prescription has the potential to revolutionize contraception access, signifying a major milestone in women’s reproductive choices. The introduction of Opill underscores Perrigo’s firm dedication to providing transformative solutions that genuinely improve lives and illustrates a commitment to pioneering impactful innovations in healthcare.
Oral Contraceptive Pills Market Leading Companies And Competitive Benchmarking
Major companies operating in the oral contraceptive pills market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Zydus Lifesciences Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc., Glenmark Pharmaceuticals, Mankind Pharma Ltd., Mayne Pharma, HLL Lifecare Limited, Famy Care Ltd., Mylan N.V., GlaxoSmithKline plc, Piramal Enterprises Ltd., Syzygy Healthcare, V Care Pharma
View The Full Oral Contraceptive Pills Market Report:
Oral Contraceptive Pills Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the oral contraceptive pills market in 2025. The Middle East is expected to be the largest growing region in the forecast period. The regions covered in the oral contraceptive pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
